The Nano-Oncology line is based on the use of nanotechnology and nano-materials for the development of new nano-systems that enable the diagnosis, evaluation and monitoring of cancer. The aim is to produce technologies and products with clinical applications. To this end, we focus mainly on the synthesis of nano-systems to create nano structures that can improve the current tools used in liquid biopsies.
Dra. Ana Belén Dávila Ibañez is head of the Nano-Oncology line of the Roche-Chus Joint Unit.